Back to Search
KYRIAKOS PAPADOPOULOS, M.D.
M.D.
Hematology & Oncology Physician
NPI: 1376546861IndividualAccepts Medicare
Specialties, Licenses & Credentials
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
L8877(TX)
CMS Specialties
PrimaryHEMATOLOGY/ONCOLOGY
Education
OTHER
Class of 1985
Research & Publications (20)
A phase 1 open-label, accelerated dose-escalation study of the hypoxia-activated prodrug AQ4N in patients with advanced malignancies.
PMID 18981010·Clin Cancer Res·2008
3-trial
Pilot study of tandem high-dose chemotherapy and autologous stem cell transplantation with a novel combination of regimens in patients with poor risk lymphoma.
PMID 16044139·Bone Marrow Transplant·2005
3-trial
Current chemotherapy options for thymic epithelial neoplasms.
PMID 15957970·Expert Opin Pharmacother·2005
6-review
Nanobiotechnology for the prevention of dialysis-related amyloidosis.
PMID 19379168·Ther Apher Dial·2009
4-observational
Phase I study of cetuximab, erlotinib, and bevacizumab in patients with advanced solid tumors.
PMID 18795291·Cancer Chemother Pharmacol·2009
3-trial
Satraplatin, an oral platinum, administered on a five-day every-five-week schedule: a pharmacokinetic and food effect study.
PMID 19458055·Clin Cancer Res·2009
2-rct
DNA gyrase (GyrB)/topoisomerase IV (ParE) inhibitors: synthesis and antibacterial activity.
PMID 19095445·Bioorg Med Chem Lett·2009
8-other
The effect of U-74389G on liver recovery after acute liver ischemia-reperfusion injury in a swine model.
PMID 18468628·J Surg Res·2009
7-preclinical
Temperature-induced protein release from water-in-oil-in-water double emulsions.
PMID 18543998·Langmuir·2008
7-preclinical
Phase I and pharmacokinetic study of YM155, a small-molecule inhibitor of survivin.
PMID 18824702·J Clin Oncol·2008
3-trial
Phase I, pharmacokinetic and biological correlative study of OSI-7904L, a novel liposomal thymidylate synthase inhibitor, and cisplatin in patients with solid tumors.
PMID 19047127·Clin Cancer Res·2008
3-trial
Serum levels of the osteoprotegerin, receptor activator of nuclear factor kappa-B ligand, metalloproteinase-1 (MMP-1) and tissue inhibitors of MMP-1 levels are increased in men 6 months after acute myocardial infarction.
PMID 18298349·Clin Chem Lab Med·2008
8-other
Transport characteristics of nanoscale functional zerovalent iron/silica composites for in situ remediation of trichloroethylene.
PMID 19192811·Environ Sci Technol·2008
8-other
Conditional random surveying for particle deposition on a mica surface.
PMID 17900387·Microsc Microanal·2007
8-other
Future options for imatinib mesilate-resistant tumors.
PMID 17922620·Expert Opin Investig Drugs·2007
6-review
The contrast sensitivity test in early detection of ocular changes in the relation to the type I diabetes mellitus compensation in children, teenagers, and young adults.
PMID 19075986·Recent Pat Inflamm Allergy Drug Discov·2007
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 4383 MEDICAL DR
SAN ANTONIO, TX 78229 - Phone
- (210) 593-5700
Quick Facts
- NPI
- 1376546861
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 41
- Publications
- 20
Are you this provider?
Claim Your Profile